Paul Dietze | Burnet Institute

Professor Paul Dietze

Program Director, Disease Elimination; Professor and Program Leader, National Drug Research Institute (NDRI)

Intranasal naloxone for the treatment of suspected heroin overdose.

Kerr D, Dietze P, Kelly AM

Intranasal naloxone for the treatment of suspected heroin overdose.

Mortality among injecting drug users in Melbourne: a 16-year follow-up of the Victorian Injecting Cohort Study (VICS).

Stoové MA, Dietze PM, Aitken CK, Jolley D

Mortality among injecting drug users in Melbourne: a 16-year follow-up of the Victorian Injecting Cohort Study (VICS).

Attitudes of Australian heroin users to peer distribution of naloxone for heroin overdose: perspectives on intranasal administration.

Kerr D, Dietze P, Kelly AM, Jolley D

Attitudes of Australian heroin users to peer distribution of naloxone for heroin overdose: perspectives on intranasal administration.

Methadone- and buprenorphine-related ambulance attendances: a population-based indicator of adverse events.

Nielsen S, Dietze P, Cantwell K, Lee N, Taylor D

Methadone- and buprenorphine-related ambulance attendances: a population-based indicator of adverse events.

Contemporary cocaine use patterns and associated harms in Melbourne and Sydney, Australia.

Shearer J, Johnston J, Fry CL, Kaye S, Dillon P, Dietze P, Collins L

Contemporary cocaine use patterns and associated harms in Melbourne and Sydney, Australia.

The incidence and characteristics of volatile substance use related ambulance attendances in metropolitan Melbourne, Australia.

Cvetkovski S, Dietze P

The incidence and characteristics of volatile substance use related ambulance attendances in metropolitan Melbourne, Australia.

50
51
52
53
54
55

Subscribe to Burnet